Soleno Therapeutics (SLNO) News Today $79.80 +2.07 (+2.66%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$79.97 +0.17 (+0.21%) As of 06/10/2025 06:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SLNO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period California State Teachers Retirement System Has $988,000 Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)California State Teachers Retirement System increased its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 23.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 21,977 shares of the company's stock after acquiringJune 11 at 3:49 AM | marketbeat.comCantor Fitzgerald Comments on SLNO FY2026 EarningsSoleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Soleno Therapeutics in a report released on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska expects that the company will postJune 10 at 8:30 AM | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 5,462 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 24.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owJune 10 at 3:16 AM | marketbeat.comNuveen Asset Management LLC Has $2.84 Million Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Nuveen Asset Management LLC grew its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 6.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 63,105 shares of the company's stock after buying an addiJune 3, 2025 | marketbeat.comWellington Management Group LLP Grows Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Wellington Management Group LLP lifted its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 14.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 782,265 shares of the company's stockJune 1, 2025 | marketbeat.comAmeriprise Financial Inc. Increases Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Ameriprise Financial Inc. grew its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 25.9% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 35,106 shares of the company's stock after buying an additional 7,223 shares during the period. AJune 1, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. boosted its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 296.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 125,400 shares of the company's stock after acquiring an additional 93,800 sharesMay 28, 2025 | marketbeat.comQ2 EPS Estimate for Soleno Therapeutics Boosted by AnalystSoleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) - Investment analysts at HC Wainwright raised their Q2 2026 earnings estimates for shares of Soleno Therapeutics in a research report issued on Friday, May 23rd. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earMay 27, 2025 | marketbeat.comToronto Dominion Bank Makes New $1.17 Million Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Toronto Dominion Bank bought a new position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 25,923 shares of the company's stock, valued at approximatelyMay 26, 2025 | marketbeat.comSoleno Therapeutics seeking regulatory approval in treatment of PWSMay 24, 2025 | finance.yahoo.comSoleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XRMay 24, 2025 | finance.yahoo.comSoleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XRMay 24, 2025 | finance.yahoo.comWoodline Partners LP Reduces Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Woodline Partners LP trimmed its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 25.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 301,562 shares of the company's stock after selling 100,521 sMay 24, 2025 | marketbeat.comSoleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of ...May 23, 2025 | finance.yahoo.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Sold by Frazier Life Sciences Management L.P.Frazier Life Sciences Management L.P. cut its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 20.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 699,159 sMay 23, 2025 | marketbeat.comSoleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XRMay 23, 2025 | insidermonkey.comSoleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi SyndromeMay 22, 2025 | globenewswire.comNationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Acquires Shares of 299,244 Soleno Therapeutics, Inc. (NASDAQ:SLNO)Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. bought a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investorMay 22, 2025 | marketbeat.comUnion Square Park Capital Management LLC Acquires Shares of 50,000 Soleno Therapeutics, Inc. (NASDAQ:SLNO)Union Square Park Capital Management LLC bought a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 50,000 sMay 22, 2025 | marketbeat.comRafferty Asset Management LLC Acquires 9,847 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Rafferty Asset Management LLC raised its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 17.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 66,480 shares of the company's stock after buying an addiMay 22, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Average Recommendation of "Buy" from BrokeragesShares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have received a consensus recommendation of "Buy" from the nine analysts that are presently covering the firm, MarketBeat.com reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned aMay 22, 2025 | marketbeat.comSoleno Therapeutics Presents Positive Clinical Data for VYKAT™ XR at the 2025 Pediatric Endocrine Society Annual MeetingMay 21, 2025 | nasdaq.comVestal Point Capital LP Buys 340,000 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Vestal Point Capital LP lifted its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 47.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,060,000 shares of the company'sMay 21, 2025 | marketbeat.comDeutsche Bank AG Purchases 36,971 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Deutsche Bank AG grew its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 44.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 119,455 shares of the company's stock after buying an additMay 21, 2025 | marketbeat.comSoleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in Participants with Prader-Willi SyndromeMay 20, 2025 | globenewswire.comTang Capital Management LLC Buys New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Tang Capital Management LLC purchased a new stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 50,000 shares of the company's stock, valuedMay 20, 2025 | marketbeat.comTema Etfs LLC Makes New Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Tema Etfs LLC acquired a new position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 13,178 shares of the company's stock, valued at approximately $592,000. A number of other instMay 20, 2025 | marketbeat.comNorthern Trust Corp Buys 34,309 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Northern Trust Corp raised its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 17.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 226,889 shares of the company's stock after acquiring anMay 20, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Position Boosted by Ensign Peak Advisors IncEnsign Peak Advisors Inc increased its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 95.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,201 shares of the company's stock afMay 19, 2025 | marketbeat.comPolar Asset Management Partners Inc. Raises Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Polar Asset Management Partners Inc. boosted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 296.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 125,400 shares of the compMay 18, 2025 | marketbeat.comBNP Paribas Financial Markets Purchases New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)BNP Paribas Financial Markets purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 71,320 shares of the company's stock, valued at approximately $3,2May 18, 2025 | marketbeat.comJanus Henderson Group PLC Boosts Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Janus Henderson Group PLC raised its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 27.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,188,265 shares of the company's stock after purchasing aMay 14, 2025 | marketbeat.comSoleno Therapeutics Announces Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ISPOR 2025May 13, 2025 | finance.yahoo.comFred Alger Management LLC Boosts Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Fred Alger Management LLC lifted its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 140.9% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,805 shares of the company's stock after buying an addiMay 13, 2025 | marketbeat.comSLNO FY2025 EPS Estimate Decreased by Cantor FitzgeraldSoleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) - Equities research analysts at Cantor Fitzgerald dropped their FY2025 EPS estimates for shares of Soleno Therapeutics in a report issued on Thursday, May 8th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earninMay 13, 2025 | marketbeat.comCrestline Management LP Purchases Shares of 12,943 Soleno Therapeutics, Inc. (NASDAQ:SLNO)Crestline Management LP acquired a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,943 shares ofMay 12, 2025 | marketbeat.comIs Soleno Therapeutics (SLNO) the Best Performing Healthcare Stock to Buy Now?May 11, 2025 | insidermonkey.comFarallon Capital Management LLC Buys New Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Farallon Capital Management LLC acquired a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 90,000 shares of the company's stock, valued at apMay 11, 2025 | marketbeat.comRobert W. Baird Increases Soleno Therapeutics (NASDAQ:SLNO) Price Target to $105.00Robert W. Baird increased their target price on shares of Soleno Therapeutics from $102.00 to $105.00 and gave the stock an "outperform" rating in a research note on Thursday.May 10, 2025 | marketbeat.comSoleno Therapeutics Announces Oral Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ESPE and ESE 2025May 9, 2025 | uk.finance.yahoo.comSoleno Therapeutics Inc (SLNO) Q1 2025 Earnings Call Highlights: Navigating Early Success and ...May 8, 2025 | finance.yahoo.comSoleno Therapeutics (NASDAQ:SLNO) Hits New 52-Week High - What's Next?Soleno Therapeutics (NASDAQ:SLNO) Reaches New 12-Month High - Should You Buy?May 8, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Lifted by Tower Research Capital LLC TRCTower Research Capital LLC TRC grew its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 811.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 4,304 shares of the company's stock after acquiring an additional 3,832 shares during thMay 8, 2025 | marketbeat.comSoleno Therapeutics, Inc. (SLNO) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comSoleno Therapeutics shares rise on VYKAT XR launch updateMay 7, 2025 | in.investing.comSoleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports First Quarter 2025 Financial ResultsMay 7, 2025 | globenewswire.comAlyeska Investment Group L.P. Sells 552,024 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Alyeska Investment Group L.P. lowered its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 56.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 424,081 shares of the company's stock aftMay 7, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Comerica BankComerica Bank grew its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 242.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 121,213 shares of the compMay 7, 2025 | marketbeat.comInvesco Ltd. Lowers Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Invesco Ltd. trimmed its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 96.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,012 shares of the company's stock after selling 322,157 shaMay 6, 2025 | marketbeat.comMariner LLC Purchases New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Mariner LLC acquired a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 9,303 shares of the companyMay 5, 2025 | marketbeat.com Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address SLNO Media Mentions By Week SLNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼1.671.01▲Average Medical News Sentiment SLNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼45▲SLNO Articles Average Week Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Smith & Nephew News Solventum News Penumbra News Stevanato Group News Glaukos News Inari Medical News iRhythm Technologies News TransMedics Group News Bausch + Lomb News Inspire Medical Systems News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SLNO Stock Free SLNO Stock Alerts